Clearline Capital »

Avita Therapeutics shares owned by Clearline Capital

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Clearline Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $284k 21k 13.72
2023-09-30 $302k 21k 14.61
2023-06-30 $856k 50k 17.01
2023-03-31 $703k 50k 13.97
2022-12-31 $332k 50k 6.60
2022-09-30 $265k 50k 5.26
2022-06-30 $239k 50k 4.75
2022-03-31 $427k 50k 8.48
2021-12-31 $603k 50k 11.98
2021-09-30 $892k 50k 17.72
2021-06-30 $1.0M 50k 20.52
2021-03-31 $781k 39k 19.82
2020-12-31 $1.7M 91k 18.58